Big data from electronic health records for early and late translational cardiovascular research: challenges and potential
Year: 2017
Type: review
Abstract: Aims: Cohorts of millions of people's health records, whole genome sequencing, imaging, sensor, societal and publicly available data present a rapidly expanding digital trace of health. We aimed to critically review, for the first time, the challenges and potential of big data across early and late stages of translational cardiovascular disease research. Methods and results: We sought exemplars based on literature reviews and expertise across the BigData@Heart Consortium. We identified formidable challenges including: data quality, knowing what data exist, the legal and ethical framework for their use, data sharing, building and maintaining public trust, developing standards for defining disease, developing tools for scalable, replicable science and equipping the clinical and scientific work force with new inter-disciplinary skills. Opportunities claimed for big health record data include: richer profiles of health and disease from birth to death and from the molecular to the societal scale; accelerated understanding of disease causation and progression, discovery of new mechanisms and treatment-relevant disease sub-phenotypes, understanding health and diseases in whole populations and whole health systems and returning actionable feedback loops to improve (and potentially disrupt) existing models of research and care, with greater efficiency. In early translational research we identified exemplars including: discovery of fundamental biological processes e.g. linking exome sequences to lifelong electronic health records (EHR) (e.g. human knockout experiments); drug development: genomic approaches to drug target validation; precision medicine: e.g. DNA integrated into hospital EHR for pre-emptive pharmacogenomics. In late translational research we identified exemplars including: learning health systems with outcome trials integrated into clinical care; citizen driven health with 24/7 multi-parameter patient monitoring to improve outcomes and population-based linkages of multiple EHR sources for higher resolution clinical epidemiology and public health. Conclusion: High volumes of inherently diverse ('big') EHR data are beginning to disrupt the nature of cardiovascular research and care. Such big data have the potential to improve our understanding of disease causation and classification relevant for early translation and to contribute actionable analytics to improve health and healthcare.
Source: European Heart Journal
Institutions: University College London Hospitals NHS Foundation Trust, National Institute for Health and Care Research, UCL Biomedical Research Centre, Farr Institute, University College London, University Medical Center Utrecht, University of Cambridge, King's College London, European Society of Cardiology, Vifor Pharma (Switzerland), Bayer (Germany), Universitätsmedizin Göttingen, Berlin-Brandenburger Centrum für Regenerative Therapien, Stiftung Charité, Charité – Universitätsmedizin Berlin
Language: English
Subfield: Health Information Management
Field: Health Professions
Domain: Health Sciences
Keywords: electronic health records, big data, cardiovascular disease, translational research, data quality, data sharing, precision medicine, pharmacogenomics, drug target validation, learning health systems, clinical epidemiology, disease classification, exome sequencing, whole genome sequencing, health data integration
Open Access status: hybrid
Estimated APC paid: $2,428
Funders: Kaiser Permanente, National Institute for Social Care and Health Research, Wellcome Trust, European Federation of Pharmaceutical Industries and Associations, Cancer Research UK, National Institute for Health and Care Research, British Heart Foundation, Arthritis Research UK, Chief Scientist Office, University College London, European Commission, European Society of Cardiology, Karolinska Institutet, Vifor Pharma, Uppsala Universitet, Innovative Medicines Initiative, Servier, Versus Arthritis, INCLIVA Instituto de Investigación Sanitaria, Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council
Awards: G1175529158, NIHR Senior Investigator Award, G1877862647, Centre for Health service and Academic Partnership in Translational eHealth Research (CHAPTER), G2259971274, G3062920068, G3335867693, Big Data 4 Better Hearts - Sofia ref.: 116074, Centre for Health service and Academic Partnership in Translational eHealth Research (CHAPTER), G434337789, G4457630332, G564525460, Systematic approaches to the evaluation of emerging coronary risk markers. Large-scale epidemiological analyses of existing data and stored biological samples (renewal), Optimising rate-control therapy in older patients with AF – a training fellowship and pilot study focused on improving quality of life, Large-scale integrative studies of risk factors in coronary heart disease: from discovery to application
OpenAlex ID: W2790916396
